Publication | Open Access
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
648
Citations
29
References
2021
Year
Gastrointestinal OncologyMedicineHer2 BlockadeImmunologyGastroenterologyPathologyKeynote-811 TrialImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyHer2-positive Gastric Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1